Overview

Detailed Summary

Dr Lalchandani Labs Limited is a diagnostic and healthcare service provider in Delhi/NCR, offering a range of pathology and diagnostic tests.
The company was established in 2011 and transitioned from a partnership firm to a limited company in 2017.
Dr Lalchandani Labs operates five fully equipped labs and fifteen collection centers, providing comprehensive diagnostic services.
The company has a significant presence in Delhi/NCR with partnerships in major hospitals and offers home collection services enhancing accessibility.
Dr Lalchandani Labs is NABL accredited and prioritizes high-tech diagnostic solutions, partnering with leading global suppliers.

Sector: Healthcare Services
Industry: Healthcare Service Provider
Market Cap: 7 Cr
Volatility: Low Risk
P/E Ratio: 95.9
Industry P/E: 64.9
PEG Ratio: -1.2
P/B Ratio: 0.5
52W High: 21.22
52W Low: 6.46

Sales CAGR

1Y: -7.48%
3Y: -26.63%
5Y: -6.11%
10Y: —

Profit CAGR

1Y: -32.26%
3Y: -23.54%
5Y: -2.53%
10Y: —

ROE

TTM: 0.45%
3Y: -1.86%
5Y: 2.92%
10Y: —

ROCE

TTM: 0.71%
3Y: 2.82%
5Y: 7.64%
10Y: —

Technicals

‌

Forecasts

Peers

Healthcare Healthcare Healthcare Services Healthcare Service Provider

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
ZDHJERK		24.24	10 Cr	25.46	0.95	0.00	3.81	3.50	2.22
LOOKS		9.40	10 Cr	329.00	0.66	0.00	0.16	0.21	0.19
CTLLAB		40.00	9 Cr	21.74	0.99	0.00	4.52	6.80	3.67
DLCL		7.98	7 Cr	95.86	0.47	0.00	0.45	0.71	0.40
TATIASKYLN		5.02	6 Cr	-50.17	0.54	0.00	-1.16	0.77	-0.80
GIANLIFE		4.93	5 Cr	-5.29	0.27	0.00	-3.76	-1.02	-2.81
BOSTONBIO		4.73	3 Cr	-5.71	0.62	0.00	-10.91	0.16	-7.87
Median: 7 Co.	—	7.98	7 Cr	21.74	0.62	0.00	0.16	0.71	0.19

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Standalone Half Yearly Results (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Sep 2021	Mar 2022	Sep 2022	Mar 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026
Sales	8.02	3.26	2.28	2.76	2.73	2.08	2.13	2.33	2.05	2.13
Expenses	6.08	2.81	2.45	2.49	2.38	1.05	1.59	1.82	1.80	2.00
Interest	0.24	0.33	0.48	0.51	0.11	0.28	0.05	0.03	0.01	0.01
Operating Profit	1.94	0.45	-0.17	0.27	0.35	1.03	0.54	0.51	0.25	0.13
OPM %	24.19	13.80	-7.46	9.78	12.82	49.52	25.35	21.89	12.20	6.10
Other Income	0.00	0.00	0.01	0.00	0.00	0.24	0.00	0.00	0.29	0.00
Depreciation	0.28	0.30	0.33	0.34	0.33	0.29	0.28	0.28	0.28	0.29
Profit Before Tax	1.43	-0.18	-0.97	-0.59	-0.09	0.71	0.20	0.20	0.26	-0.16
Tax %	25.17	27.78	0.00	0.00	0.00	0.00	25.00	-35.00	26.92	18.75
Net Profit	1.07	-0.13	-0.97	-0.59	-0.09	0.71	0.15	0.27	0.20	-0.13
EPS in Rs	—	—	—	—	—	—	—	—	—	—

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	2.79	5.26	6.10	9.78	11	5.04	4.81	4.45
Expenses	2.17	4.06	4.84	7.56	8.87	4.96	4.61	3.53
Operating Profit	0.62	1.20	1.27	2.22	2.41	0.08	0.20	0.92
OPM %	22.11	22.78	20.79	22.69	21.33	1.65	4.15	20.73
Other Income	0.03	0.01	0.00	0.00	0.00	0.00	1.43	0.13
Interest	0.16	0.14	0.18	0.33	0.53	0.99	0.38	0.09
Depreciation	0.13	0.35	0.42	0.52	0.59	0.66	0.62	0.56
Profit Before Tax	0.35	0.72	0.66	1.38	1.29	-1.56	0.62	0.40
Tax %	26.00	25.79	28.23	26.58	27.48	0.00	0.00	-3.73
Net Profit	0.26	0.53	0.47	1.01	0.93	-1.56	0.62	0.42
EPS in Rs	—	—	—	—	—	—	—	—
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	2.93	4.33	4.33	4.33	4.33	4.33	4.33	4.33
Reserves	0.40	3.73	4.21	5.22	6.15	4.59	5.21	5.62
Borrowings	1.34	0.65	1.51	3.40	4.04	4.68	3.40	4.07
Other Liabilities	1.53	1.42	1.89	2.25	3.60	4.11	2.05	1.72
Total Liabilities	6.21	10	12	15	18	18	15	16
Fixed Assets	2.06	3.28	3.47	5.24	5.75	5.39	3.99	3.51
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.24	0.24	0.24	0.24	0.24	0.24	0.41	0.27
Other Assets	3.91	6.62	8.22	9.71	12	12	11	12
Total Assets	6.21	10	12	15	18	18	15	16

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	0.58	-0.45	-0.10	1.19	2.01	0.00	-0.22	0.37
Cash from Investing Activity	-1.29	-1.95	-0.53	-2.26	-1.53	-0.20	1.00	0.06
Cash from Financing Activity	1.57	3.51	0.85	1.71	0.16	-0.23	-1.59	0.58
Net Cash Flow	0.85	1.12	0.23	0.64	0.64	-0.43	-0.81	1.01

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Sep 2020	Mar 2021	Sep 2021	Mar 2022	Sep 2022	Mar 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026
Promoters	60.78%	60.78%	60.78%	60.78%	60.78%	60.78%	60.78%	60.78%	57.18%	48.32%	31.15%	32.90%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	39.22%	39.22%	39.22%	39.22%	39.22%	39.22%	39.22%	39.22%	42.82%	51.68%	68.85%	67.10%
Total Shareholders	143	143	151	157	162	164	159	165	181	246	206	234

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

Actions

Action Type

‌
‌

Announcements

Last 7 days

Sentiment

Sorry, no results found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

Ask AI

Frequently Asked Questions about Dr Lalchandani Labs Ltd

Dr Lalchandani Labs Ltd (DLCL) is currently trading at 7.98 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Dr Lalchandani Labs Limited is a diagnostic and healthcare service provider in Delhi/NCR, offering a range of pathology and diagnostic tests. The company was established in 2011 and transitioned from a partnership firm to a limited company in 2017. Dr Lalchandani Labs operates five fully equipped labs and fifteen collection centers, providing comprehensive diagnostic services. The company has a significant presence in Delhi/NCR with partnerships in major hospitals and offers home collection services enhancing accessibility. Dr Lalchandani Labs is NABL accredited and prioritizes high-tech diagnostic solutions, partnering with leading global suppliers.

Over the past 52 weeks, Dr Lalchandani Labs Ltd has traded between a low of ₹6.46 and a high of ₹21.22. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Dr Lalchandani Labs Ltd has a market capitalization of approximately 6.71. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Dr Lalchandani Labs Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 95.86 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 6.71 Cr, Dr Lalchandani Labs Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Dr Lalchandani Labs Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Dr Lalchandani Labs Ltd is 95.86. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Dr Lalchandani Labs Ltd

Stock Summary and Key Metrics

Investment Checklist

Investment Checklist

Overview

Financial Ratios

Technicals

Forecasts

Peers

Price Chart Comparison